•  
  •  
  •  
  •  

2026-05-24 00:00:12

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores

Keywords Selected:  CDMO

Stock Report

  • OneSource Supports Second Generic Semaglutide Approval in Canada
  • Windlas Biotech Announces ₹47 Crore Share Buyback at ₹1,000 per Share
  • Saharsh Davuluri takes over as CEO & MD of Neuland and will lead the next phase of CDMO expansion
  • Morepen Laboratories bags ₹825 Crore Global Deal
  • Cohance Lifesciences Appoints Yann D'Herve as CEO of CDMO Business, Effective August 1, 2025
  • OneSource and Xbrane Biopharma Announce Biosimilars Manufacturing Partnership for the Global Markets
  • Remedium Lifecare Enhances R&D and CDMO, Secures ₹182.7 Crore Export Deal
  • Medicamen Biotech Limited signs CDMO contract with XGX Pharma
  • Suven to acquire controlling stake in NJ Bio, Inc., an ADC specialist player
  • Shilpa Medicare Ltd's CDMO customer receives Fast-Track Designation for its investigational drug candidate
  • OneSource receives equity commitments of INR 8,010 mn from marquee investors at a pre-money equity valuation of USD 1.65 bn
  • Piramal Pharma Solutions announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
  • Advent International announces the completion of the acquisition of Suven Pharma
  • Coromandel International Ltd enters into Specialty and Industrial Chemicals, foray into CDMO and expansion in Crop Protection Chemicals
  • Tube Investments of India Ltd forays into Contract Development and Manufacturing Organization
  • Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
  • Windlas Biotech Limited receives EU-GMP certificate
  • Windlas Biotech receives certificate of Good Manufacturing Practices from SAHPRA
  • Windlas Biotech Limited Strengthens Senior Management Capability

Latest Post

  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025